ArticlePeerJ2025
Neonatal hearing screening among high-risk newborns in Northwestern Nigeria.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prevalence and risk factors for failed newborn hearing screening among preterm infants: a prospective cohort study in Nairobi, Kenya.BMJ paediatrics open · 2026Article
- Universal newborn hearing screening in Southwest Iran: coverage, risk factors, and outcomes in a large-scale population.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
- Paediatric Audiology: An analysis of stakeholder perspectives on advancement in Early Hearing Detection and Intervention for deaf infants in Nigeria.Journal of otology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neonatal Intensive Care Unit (NICU) patients are at an increased risk of developing hearing loss. Given the critical role of normal hearing in speech and language development, early detection and treatment of this condition in children are paramount. Methods: Hearing assessments were performed using transient evoked otoacoustic emission (TEOAE) and automated auditory brain stem response (AABR) tests on 60 neonates. The resulting data were analysed using R version 4.3.3. Results: Out of the 60 neonates enrolled in the study, 57% were males and 43% were females, and their ages ranged from 1 to 30 days. A total of 43 (71.7%) neonates passed both hearing tests, while 17 (28.3%) failed. In the unadjusted analysis, low birth weight, prematurity, birth asphyxia, and gestational age were significantly associated with neonatal hearing screening failure. Premature neonates and those with low birth weight had markedly higher odds of failing the screening (Odds Ratio (OR) = 24.4; 95% confidence interval (CI) [5.85-135.0] and OR = 12.3; 95% CI [3.5-50.6], respectively), while gestational age was associated with lower odds of failure (OR = 0.59; 95% CI [0.43-0.76]). In the multivariable model, after accounting for multicollinearity, only gestational age remained a statistically significant predictor, with each additional week associated with reduced odds of screening failure (adjusted OR = 0.60; 95% CI [0.43-0.80]). Conclusion: Our findings underscore the importance of early screening for hearing loss in high-risk neonates in the NICU to facilitate timely interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.